U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06873100) titled 'Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis' on Feb. 26.
Brief Summary: Relapsing polychondritis (RP) is a rare, systemic autoimmune disorder characterized by episodic inflammation of cartilaginous structures.
The goal of this clinical trial is to learn if drug Upadacitinib works to treat relapsing polychondritis in adults. It will also learn about the safety of drug Upadacitinib. The main questions it aims to answer are:
* Does drug Upadacitinib reduce the disease activity of relapsing polychondritis?
* What medical problems do participants have when taking drug Upadacitinib? Resea...